Portfolio Co Investors 2026 for Novo Holdings: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Novo Holdings accounts for 70 tracked companies with verified cap-table data, 70 of which disclose round sizes totalling $17B. The median disclosed raise is $150M, and the largest is Morphic Therapeutic at $3.2B, ahead of Tempus ($1.4B) and Noom ($718M).
The names that recur most often on these co-invested cap tables are Novo Holdings (70 companies), OrbiMed (10 companies), SR One (7 companies), Forbion (7 companies), RA Capital Management (6 companies), Janus Henderson Investors (6 companies). By latest disclosed round, the market skews Series A (22), Series B (16), Series C (11), IPO (5).
Companies tracked: 70
Disclosed funding total: $17B across 70 companies
Median disclosed raise: $150M
Largest raise: Morphic Therapeutic — $3.2B
Stage mix: Series A 22 · Series B 16 · Series C 11 · IPO 5
